RichardJRodehefferMD
Cardiology • Rochester, MNAdult Congenital Heart Disease, Heart Failure & Transplantation
Professor of Medicine Mayo Clinic
Dr. Rodeheffer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st Street SW
Rochester, MN 55905
Summary
- My focus is in clinical care and research in the area of heart failure and cardiac transplantation. On coming to Mayo Clinic in 1987, I co-founded our transplnat program and founded our Heart Failure Clinic.
Education & Training
Johns Hopkins UniversityFellowship, Cardiovascular Disease, 1982 - 1983- Johns Hopkins UniversityResidency, Internal Medicine, 1977 - 1981
University of Rochester School of Medicine and DentistryClass of 1977
Certifications & Licensure
WI State Medical License 2014 - 2025
MN State Medical License 1987 - 2024
TN State Medical License 1984 - 1987
MD State Medical License 1979 - 1985- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Prevalence of Asymptomatic Ventricular Dysfunction Start of enrollment: 1997 Jan 01
Publications & Presentations
PubMed
- Association of Impaired Relaxation Mitral Inflow Pattern (Grade 1 Diastolic Function) with Long-term Non-Cardiovascular and Cardiovascular Mortality.Kathleen A Young, Richard J Rodeheffer, Jared G Bird, William R Miranda, Horng H Chen
Journal of the American Society of Echocardiography. 2025-01-15 - Association of cardiac biomarkers with long-term cardiovascular events in a community cohort.Robert A Churchill, Benjamin R Gochanour, Christopher G Scott, Vlad C Vasile, Richard J Rodeheffer
Biomarkers. 2024-06-01 - Inhibition of angiogenesis in the management of refractory gastrointestinal bleeding in patients with LVAD support.Sara S Inglis, Rabea Asleh, Vivek N Iyer, Sarah D Schettle, Philip J Spencer
Artificial Organs. 2024-06-01
Other
- Development of malignancy following solid organ transplantationRodeheffer RJ, Brennan DC, Ambinder RF
http://www.uptodate.com/contents/development-of-malignancy-following-solid-organ-transplantation
UpToDate, Wolters Kluwer Health - 2013-04-18
Authored Content
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Join now to see all
Press Mentions
Diabetes Kann Unabhängig Zu Herzinsuffizienz Führen, Wie Eine Bevölkerungsstudie ZeigtJanuary 6th, 2020- Selon Une Étude Portant Sur Une Population, Le Diabète Peut Entraîner Indépendamment Une Insuffisance CardiaqueJanuary 6th, 2020
Grant Support
- Prevalence Of Asymptomatic Ventricular DysfunctionNational Center For Research Resources2004–2005
- Prevalence Of Asymptomatic Ventricular DysfunctionNational Heart, Lung, And Blood Institute2004
- Prevalence Of Asymptomatic Ventricular DysfunctionNational Heart, Lung, And Blood Institute1997–2003
- Prevalence Of Asymptomatic Ventricular DysfunctionNational Center For Research Resources2000–2002
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
